Lilia-Celine Lozada
JPMorgan Chase & Co, Research Division
Hi, everyone. Thanks for joining. I’m Lily Lozada. I’m part of the med tech team here at JPMorgan. Very happy to have the Dentsply Sirona team with us here with us today.
I’ll pass it over to CEO, Dan Scavilla, and then we’ll do some Q&A afterwards.
Daniel Scavilla
President, CEO, Interim Principal Financial Officer & Director
Thanks, Lily, and good afternoon, everyone. My name is Dan Scavilla, CEO of Dentsply Sirona. I joined the team five months ago. Prior to that, I spent 10.5 years at Globus Medical in various roles, including CFO, COO and CEO. There, we actually had a great opportunity of taking our revenue from $300 million to $3 billion. And in doing that, really focus on sustained profitable growth, and delivering best-in-class margins in the med dev arena.
Prior to that, I had 28 years with Johnson & Johnson. There, I had worked in pharmaceutical, biologics, consumer health care and med dev. In J&J, that gave me an exposure to multiple areas in the health care environment, also taught me a lot of business models that I feel are applicable today.
I joined Dentsply Sirona, and I may refer to that as DS or Dentsply Sirona, I may call DS as we go through this conversation. Really, when I realized the strength of our brands, the brand loyalty that we have with our customers and the fact that we have an integrated portfolio that really will allow us to shape the future of dentistry and connected dentistry using our
